Concepedia

Saru Basnet

SB

Statistics

Publications

13

Citations

298

H-Index

12

Active since

2020

Affiliations

University of Helsinki(Current)

Helsinki University Hospital

Biocenter Finland

Finnish Food Authority

Hospital District of Helsinki and Uusimaa

Saru Basnet is an author at University of Helsinki specializing in oncology, adenovirus vectors, and immunology.

Publications per year

2020–2025

13

Publications

13

Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer

James H.A. Clubb, Tatiana V. Kudling, Camilla Heiniö et al. · Frontiers in Immunology · 2022 · 47 citations · Full text

Life Sciences, Immunology, Oncology +17

Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control

Dafne C.A. Quixabeira, Sadia Zafar, João M. Santos et al. · Frontiers in Immunology · 2021 · 37 citations · Full text

Medicine, Immunology, Oncology +17

Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression

Tatiana V. Kudling, James H.A. Clubb, Dafne C.A. Quixabeira et al. · OncoImmunology · 2022 · 35 citations · Full text

Medicine, Immunology, Oncology +17

The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial

Matthew S. Block, James H.A. Clubb, Johanna Mäenpää et al. · Nature Communications · 2025 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples

Sadia Zafar, Saru Basnet, Inga-Maria Launonen et al. · Human Gene Therapy · 2020 · 28 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 13